CIK 0001746466 · Non-accelerated filer<br>Smaller reporting company
Equillium, Inc.
Sign in to watch- Ticker
- EQ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821554746
- Phone
- (858) 412-5302
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, 92037
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-14 | Zedelmayer Christine Sr. Vice President and COO | Returned to the company · Employee Stock Option (right to buy) | −175,000 | 0 | ||
| 2025-02-14 | Connelly Stephen Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2025-02-14 | Connelly Stephen Chief Scientific Officer | Returned to the company · Employee Stock Option (right to buy) | −90,000 | 0 | ||
| 2025-02-14 | Connelly Stephen Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +52,500 | 52,500 | ||
| 2025-02-14 | Connelly Stephen Chief Scientific Officer | Returned to the company · Employee Stock Option (right to buy) | −52,500 | 0 | ||
| 2025-02-14 | Connelly Stephen Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2025-02-14 | Connelly Stephen Chief Scientific Officer | Returned to the company · Employee Stock Option (right to buy) | −100,000 | 0 | ||
| 2025-02-14 | Connelly Stephen Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +42,534 | 42,534 | ||
| 2025-02-14 | Connelly Stephen Chief Scientific Officer | Returned to the company · Employee Stock Option (right to buy) | −42,534 | 0 | ||
| 2025-02-14 | Connelly Stephen Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2025-02-14 | Connelly Stephen Chief Scientific Officer | Returned to the company · Employee Stock Option (right to buy) | −125,000 | 0 | ||
| 2025-02-14 | Connelly Stephen Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2025-02-14 | Connelly Stephen Chief Scientific Officer | Returned to the company · Employee Stock Option (right to buy) | −175,000 | 0 | ||
| 2025-02-14 | BRADBURY DANIEL EXECUTIVE CHAIRMAN | Grant or award · Employee Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2025-02-14 | BRADBURY DANIEL EXECUTIVE CHAIRMAN | Returned to the company · Employee Stock Option (right to buy) | −90,000 | 0 | ||
| 2025-02-14 | BRADBURY DANIEL EXECUTIVE CHAIRMAN | Grant or award · Employee Stock Option (right to buy) | +36,000 | 36,000 | ||
| 2025-02-14 | BRADBURY DANIEL EXECUTIVE CHAIRMAN | Returned to the company · Employee Stock Option (right to buy) | −36,000 | 0 | ||
| 2025-02-14 | BRADBURY DANIEL EXECUTIVE CHAIRMAN | Grant or award · Employee Stock Option (right to buy) | +28,708 | 28,708 | ||
| 2025-02-14 | BRADBURY DANIEL EXECUTIVE CHAIRMAN | Returned to the company · Employee Stock Option (right to buy) | −28,708 | 0 | ||
| 2025-02-14 | BRADBURY DANIEL EXECUTIVE CHAIRMAN | Grant or award · Employee Stock Option (right to buy) | +36,000 | 36,000 |
Page 5 of 17 · 339 trades